Skip to main content
Log in

Spinal inflammation by magnetic resonance imaging in patients with ankylosing spondylitis: association with disease activity and outcome parameters

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Magnetic resonance imaging (MRI) has major contribution in early diagnosis of ankylosing spondylitis (AS). As it is difficult to determine disease activity owing to the lack of close relation between laboratory tests, clinical findings and imaging, MRI has been used as an objective outcome measure. The aim of this study is to investigate the relation between spinal MRI findings with disease activity and other outcome measures. Fifty patients fulfilling modified New York criteria for AS were enrolled to the study. All the patients were evaluated with Bath AS Disease Activity Index (BASDAI), AS Disease Activity Score (ASDAS), Bath AS Functional Index (BASFI), Bath AS Metrology Index (BASMI), Bath AS Radiology Index (BASRI) and As Quality of Life. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were measured as laboratory parameters, and ASspiMR scores were determined by spinal MRI. The median total ASspiMR-a score was 5.2. Spinal inflammation was evaluated in spinal segments, and thoracic segments had the highest mean ASspiMR-a level (3.1 ± 5.94). Cervical and lumbar ASspiMR were correlated with only BASRI, and total ASspiMR score was correlated with BASRI, BASMI and CRP. Thoracic ASspiMR score was correlated with patient’s and doctor’s global assessments, BASFI, BASMI, BASRI, ASDAS A, ASDAS B, ASDAS C, ASDAS D, ESR and CRP (P < 0.05). According to our results, the thoracic spine was the most related region with disease activity parameters and clinical outcome measures, so we suggest thoracic spine MRI evaluation in order to determine the disease activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Gensler L (2011) Clinical features of ankylosing spondylitis. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (eds) Rheumatology, 5th edn. Mosby Elsevier, Philadelphia, pp 1129–1134

    Chapter  Google Scholar 

  2. Braun J, Rudwaleit M, Hermann KG, Rau R (2007) Imaging in ankylosing spondylitis. Z Rheumatol 66:167–178

    Article  PubMed  CAS  Google Scholar 

  3. Braun J, Baraliakos X, Golder W, Brandt J, Rudwaleit M, Listing J, Bollow M, Sieper J, Van Der Heijde D (2003) Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system. Arthritis Rheum 48:1126–1136

    Article  PubMed  CAS  Google Scholar 

  4. Wendling D, Toussirot E, Streit G, Prati C (2006) Imaging study scores for ankylosing spondylitis. Jt Bone Spine 73:655–660

    Article  Google Scholar 

  5. Rudwaleit M, Khan MA, Sieper J (2005) The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? Arthritis Rheum 52:1000–1008

    Article  PubMed  Google Scholar 

  6. Baraliakos X, Davis J, Tsuji W, Braun J (2005) Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept. Arthritis Rheum 52:1216–1223

    Article  PubMed  CAS  Google Scholar 

  7. Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J (2009) The Assessment of SpondyloArthritis International Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 68:1–44

    Google Scholar 

  8. Akkoc Y, Karatepe AG, Akar S, Kirazli Y, Akkoc N (2005) A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity. Rheumatol Int 25:280–284

    Article  PubMed  Google Scholar 

  9. Yanık B, Gürsel YK, Kutlay S, Ay S, Elhan AH (2005) Adaptation of the Bath Ankylosing Spondylitis Functional Index to the Turkish population, its reliability and validity: functional assessment in AS. Clin Rheumatol 24:41–47

    Article  PubMed  Google Scholar 

  10. Jenkinson TR, Mallorie PA, Whitelock HC (1994) Defining spinal mobility in ankylosing spondylitis (AS): the Bath AS Metrology Index. J Rheumatol 21:694–698

    Google Scholar 

  11. Madsen OR, Hansen LB, Rytter A, Suetta C, Egsmose C (2009) The bath metrology index as assessed by a trained and an untrained rater in patients with spondyloarthropathy: a study of intra- and inter-rater agreements. Clin Rheumatol 28:35–40

    Article  PubMed  CAS  Google Scholar 

  12. MacKay K, Mack C, Brophy S, Calin A (1998) The Bath Ankylosing Spondylitis Radiology Index (BASRI): a new, validated approach to disease assessment. Arthritis Rheum 41:2263–2270

    Article  PubMed  CAS  Google Scholar 

  13. Tuncay Duruöz LD, Cerrahoglu L, Turan Y, Sari H (2008) Translation and validation of the Turkish version of the ankylosing spondylitis quality of life (ASQOL) questionnaire. Ann Rheum Dis 67(Suppl II):623

    Google Scholar 

  14. Lukas C, Landewé R, Sieper J (2009) Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 68:18–24

    Article  PubMed  CAS  Google Scholar 

  15. Van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J, Braun J, Landewé R, Assessment of SpondyloArthritis international Society (ASAS) (2009) ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 68:1811–1818

    Article  PubMed  Google Scholar 

  16. Lukas C, Braun J, van der Heijde D, Hermann KG, Rudwaleit M, Østergaard M, Oostveen A, O’Connor P, Maksymowych WP, Lambert RG, Jurik AG, Baraliakos X, Landewé R (2007) Scoring inflammatory activity of the spine by magnetic resonance imaging in ankylosing spondylitis: a multireader experiment. ASAS/OMERACT MRI in AS Working Group. J Rheumatol 34:862–870

    PubMed  Google Scholar 

  17. Heikkilä S, Viitanen JV, Kautiainen H, Kauppi M (2002) Functional long-term changes in patients with spondyloarthropathy. Clin Rheumatol 21:119–122

    Article  PubMed  Google Scholar 

  18. Akdeniz O, Alaylı G, Tosun FC, Diren B, Cengiz K, Selçuk MB, Sünter T, Cantürk F (2008) Early spondyloarthropaty: scintigraphic, biological, and clinical findings in MR-positive patients. Clin Rheumatol 27:469–474

    Article  PubMed  Google Scholar 

  19. Baraliakos X, Davis J, Tsuji W, Braun J (2005) Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept. Arthritis Rheum 52:1216–1223

    Article  PubMed  CAS  Google Scholar 

  20. Baraliakos X, Hermann KG, Landewé R, Listing J, Golder W, Brandt J, Rudwailet M, Bollow M, Sieper J, van der Heijde D, Braun J (2005) Assessment of acute spinal inflammation in patients with ankylosing spondylitis by magnetic resonance imaging: a comparison contrast enhanced T1 and short tau inversion recovery (STIR) sequences. Ann Rheum Dis 64:1141–1144

    Article  PubMed  CAS  Google Scholar 

  21. van der Heijde D, Landewé R (2005) Imaging in spondylitis. Curr Opin Rheumatol 17:413–417

    Article  PubMed  Google Scholar 

  22. Braun J, Baraliakos X, Golder W, Hermann KG, Listing J, Brandt J, Rudwaleit M, Zuehlsdorf S, Bollow M, Sieper J, van der Heijde D (2004) Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional X rays with magnetic resonance imaging using established and new scoring systems. Ann Rheum Dis 63:1046–1055

    Article  PubMed  CAS  Google Scholar 

  23. Sieper J, Baraliakos X, Listing J, Brandt J, Haibel H, Rudwailet M, Braun J (2005) Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximab. Rheumatology 44:1525–1530

    Article  PubMed  CAS  Google Scholar 

  24. Baraliakos X, Landewe R, Hermann KG, Listing J, Golder W, Brandt J, Rudwaleit M, Bollow M, Sieper J, van der Heijde D, Braun J (2005) Inflammation in ankylosing spondylitis: a systematic description of the extension and frequency of acute spinal changes using magnetic resonance imaging (MRI). Ann Rheum Dis 64:730–734

    Article  PubMed  CAS  Google Scholar 

  25. Pedersen SJ, Sørensen IJ, Hermann KG, Madsen OR, Tvede N, Hansen MS, Thamsborg G, Andersen LS, Majgaard O, Loft AG, Erlendsson J, Asmussen K, Johansen JS, Jurik AG, Møller J, Hasselquist M, Mikkelsen D, Skjødt T, Hansen A, Ostergaard M (2010) Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors. Ann Rheum Dis 69:1065–1071

    Article  PubMed  Google Scholar 

  26. Romero-Sánchez C, Robinson WH, Tomooka BH, Londoňo J, Valle-Oňate R, Huang F, Deng X, Zhang L, Yang C, Yu DT (2008) Identification of acute phase reactants and cytokines useful for monitoring infliximab therapy in ankylosing spondylitis. Clin Rheumatol 27:1429–1435

    Article  PubMed  Google Scholar 

  27. Puhakka KB, Jurik AG, Schiottz-Christensen B, Magnetic resonance imaging of sacroiliitis in early seronegative spondyloarthropathy et al (2004) Abnormalities correlated to clinical and laboratory findings. Rheumatology (Oxford) 43:234–237

    Article  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dilek Keskin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Konca, Ş., Keskin, D., Cılız, D. et al. Spinal inflammation by magnetic resonance imaging in patients with ankylosing spondylitis: association with disease activity and outcome parameters. Rheumatol Int 32, 3765–3770 (2012). https://doi.org/10.1007/s00296-011-2248-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-011-2248-5

Keywords

Navigation